Medtech
As of the edition of 20 October 2026, Medtech runs 9 drugs, 9 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 9 |
| Total | 9 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Diphenhydramine | none listed | 2 |
| Cimetidine | none listed | 1 |
| Miconazole | none listed | 0 |
| Permethrin | none listed | 0 |
| Carboxymethylcellulose calcium | none listed | 0 |
| Dimenhydrinate | none listed | 0 |
| Carboxymethylcellulose sodium | none listed | 0 |
| Piperonyl butoxide | none listed | 0 |
| Pyrethrum extract | none listed | 0 |
A route B row is one company at one target.